Literature DB >> 31504124

Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States.

Tianshi David Wu, Chinedu O Ejike, Robert A Wise, Meredith C McCormack, Emily P Brigham.   

Abstract

An obesity paradox in chronic obstructive pulmonary disease (COPD), whereby overweight/obese individuals have improved survival, has been well-described. These studies have generally included smokers. It is unknown whether the paradox exists in individuals with COPD arising from factors other than smoking. Nonsmoking COPD is understudied yet represents some 25%-45% of the disease worldwide. To determine whether the obesity paradox differs between ever- and never-smokers with COPD, 1,723 adult participants with this condition were examined from 2 iterations of the National Health and Nutrition Examination Survey (1988-1994, 2007-2010), with mortality outcomes followed through December 2011. Using Cox proportional hazards models, adjusted for sociodemographic factors, lung function, and survey cycle, ever/never-smoking was found to modify the association between body mass index and hazard of death. Compared with normal-weight participants, overweight/obese participants had lower hazard of death among ever-smokers (for overweight, adjusted hazard ratio (aHR) = 0.56, 95% confidence interval (CI): 0.43, 0.74; for obesity, aHR = 0.66, 95% CI: 0.48, 0.92), but never-smokers did not (overweight, aHR = 1.41, 95% CI: 0.66, 3.03; obesity, aHR = 1.29, 95% CI: 0.48, 3.48). An obesity paradox appeared to be absent among never-smokers with COPD. This, to our knowledge, novel finding might be explained by pathophysiological differences between smoking-related and nonsmoking COPD or by smoking-associated methodological biases.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chronic obstructive pulmonary disease; mortality; obesity

Mesh:

Year:  2019        PMID: 31504124      PMCID: PMC6896239          DOI: 10.1093/aje/kwz185

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

Review 1.  Healthy obese versus unhealthy lean: the obesity paradox.

Authors:  Carl J Lavie; Alban De Schutter; Richard V Milani
Journal:  Nat Rev Endocrinol       Date:  2014-09-30       Impact factor: 43.330

2.  Grading the severity of obstruction in mixed obstructive-restrictive lung disease.

Authors:  Zechariah S Gardner; Gregg L Ruppel; David A Kaminsky
Journal:  Chest       Date:  2011-03-17       Impact factor: 9.410

3.  Body mass index and the risk of COPD.

Authors:  Raida I Harik-Khan; Jerome L Fleg; Robert A Wise
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

Review 4.  Non-smoking-related chronic obstructive pulmonary disease: a neglected entity?

Authors:  Guangqiao Zeng; Baoqing Sun; Nanshan Zhong
Journal:  Respirology       Date:  2012-08       Impact factor: 6.424

Review 5.  Body weight and mortality in COPD: focus on the obesity paradox.

Authors:  Francesco Spelta; A M Fratta Pasini; L Cazzoletti; M Ferrari
Journal:  Eat Weight Disord       Date:  2017-11-06       Impact factor: 4.652

6.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.

Authors:  M P Swanney; G Ruppel; P L Enright; O F Pedersen; R O Crapo; M R Miller; R L Jensen; E Falaschetti; J P Schouten; J L Hankinson; J Stocks; P H Quanjer
Journal:  Thorax       Date:  2008-09-11       Impact factor: 9.139

Review 7.  Chronic obstructive pulmonary disease in non-smokers.

Authors:  Sundeep S Salvi; Peter J Barnes
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

8.  National health and nutrition examination survey: plan and operations, 1999-2010.

Authors:  George Zipf; Michele Chiappa; Kathryn S Porter; Yechiam Ostchega; Brenda G Lewis; Jennifer Dostal
Journal:  Vital Health Stat 1       Date:  2013-08

9.  COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Authors:  Bernd Lamprecht; Mary Ann McBurnie; William M Vollmer; Gunnar Gudmundsson; Tobias Welte; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Eric Bateman; Josep M Anto; Peter Burney; David M Mannino; Sonia A Buist
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

10.  Selection bias: a missing factor in the obesity paradox debate.

Authors:  Whitney R Robinson; Helena Furberg; Hailey R Banack
Journal:  Obesity (Silver Spring)       Date:  2014-03       Impact factor: 5.002

View more
  10 in total

1.  THE AUTHORS REPLY.

Authors:  Tianshi David Wu; Chinedu Ejike; Robert A Wise; Meredith C McCormack; Emily P Brigham
Journal:  Am J Epidemiol       Date:  2020-05-05       Impact factor: 4.897

2.  BMI moderates the association between adverse childhood experiences and COPD.

Authors:  Megan R Westmore; Priyanjali Chakraborty; LaTisha A Thomas; Lacey Jenkins; Faheem Ohri; Philip Baiden
Journal:  J Psychosom Res       Date:  2022-07-16       Impact factor: 4.620

3.  A Dyadic Growth Modeling Approach for Examining Associations Between Weight Gain and Lung Function Decline.

Authors:  Talea Cornelius; Joseph E Schwartz; Pallavi Balte; Surya P Bhatt; Patricia A Cassano; David Currow; David R Jacobs; Miriam Johnson; Ravi Kalhan; Richard Kronmal; Laura Loehr; George T O'Connor; Benjamin Smith; Wendy B White; Sachin Yende; Elizabeth C Oelsner
Journal:  Am J Epidemiol       Date:  2020-10-01       Impact factor: 4.897

4.  Efficacy of nalmefene with noninvasive positive-pressure ventilation on elderly patients with chronic obstructive pulmonary disease combining with type II respiratory failure.

Authors:  Zhen Wu; Heyan Gu; Ronghua Tian; Xia Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study.

Authors:  Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

6.  Quantitative Analysis of Adipose Depots by Using Chest CT and Associations with All-Cause Mortality in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis from MESArthritis Ancillary Study.

Authors:  Farhad Pishgar; Mahsima Shabani; Thiago Quinaglia A C Silva; David A Bluemke; Matthew Budoff; R Graham Barr; Matthew A Allison; Wendy S Post; João A C Lima; Shadpour Demehri
Journal:  Radiology       Date:  2021-04-06       Impact factor: 29.146

7.  Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease.

Authors:  Ayse Dudu Altintas Dogan; Ole Hilberg; Søren Hess; Torben Tranborg Jensen; Else-Marie Bladbjerg; Claus Bogh Juhl
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-22

Review 8.  High-Density Lipoproteins: A Role in Inflammation in COPD.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

Review 9.  The Obesity Paradox in Chronic Heart Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Suganya Giri Ravindran; Debistuti Saha; Iffat Iqbal; Sharan Jhaveri; Chaithanya Avanthika; Mridula Sree Naagendran; Lakshmi Deepak Bethineedi; Tony Santhosh
Journal:  Cureus       Date:  2022-06-05

Review 10.  Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.